SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
Conditions
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
Interventions
- BIOLOGICAL: ADV/HSV-tk
- DRUG: Valacyclovir
- RADIATION: SBRT
- DRUG: Pembrolizumab
Sponsor
The Methodist Hospital Research Institute
Collaborators